Clinical trial
Phase 4 Study of Glucosamine Sulphate in the Treatment for Chronic Low Back Pain Patients With Degenerative Lumbar MRI Findings
NCT00404079 is registered in ClinicalTrials.gov with Ullevaal University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase 4 Study of Glucosamine Sulphate in the Treatment for Chronic Low Back Pain Patients With Degenerative Lumbar MRI Findings
- Lead sponsor
- Ullevaal University Hospital
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- December 31, 2006
- Completion date
- November 30, 2010
- Enrollment
- 250 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.